Citius Oncology (CTOR) Inventory (2024 - 2026)

Citius Oncology's Inventory history runs 3 years deep, the most recent figure standing at $22.7 million for Q1 2026.

• In Q1 2026, Inventory rose 47.72% year-over-year to $22.7 million; the TTM figure through Mar 2026 stood at $22.7 million (up 47.72% YoY), while the FY2025 annual figure was $22.3 million, up 169.53% from the prior year.
• Inventory was $22.7 million for Q1 2026 at Citius Oncology, roughly flat from $22.6 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $22.7 million in Q1 2026 to a low of $8.3 million in Q3 2024.
• Historically, Inventory has averaged $17.5 million across 3 years, with a median of $17.2 million in 2025.
• The sharpest annual moves came in 2025 and 2026: Inventory soared 169.53% in 2025, then surged 47.72% in 2026.
• A 3-year view of Inventory shows it stood at $14.4 million in 2024, then jumped by 57.42% to $22.6 million in 2025, then grew by 0.09% to $22.7 million in 2026.
• The last three Inventory figures came in at $22.7 million (Q1 2026), $22.6 million (Q4 2025), and $22.3 million (Q3 2025), per Business Quant data.